Skip to search formSkip to main contentSkip to account menu

ESHAP protocol

Known as: Cisplatin/Cytarabine/Etoposide/Methylprednisolone, ARA-C/CDDP/MePRDL/VP-16, E-SHAP 
National Institutes of Health

Related topics

Related topics

5 relations
CisplatinCytarabineESAP protocolEtoposide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A…
Introduction: 30% of Hodgkin Lymphoma (HL) patients are refractory or relapse (RR) after first line therapy. Salvage chemotherapy… 
2012
2012
Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999–2008 and treated with curative intent in the AIDS Malignancy Consortium
Abstract No comparative studies exist for relapsed/refractory (rel/rfr) acquired immune deficiency syndrome (AIDS)-related… 
2010
2010
A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for…
2006
2006
ESHAP+fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of…
From 1996 to November 2004, 131 consecutive patients with relapsed or refractory diffuse large cell lymphoma (DLCL) and Hodgkin's… 
2005
2005
ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF
Summary:The ESHAP (etoposide, methylprednisolone, high-dose cytarabine, and cisplatin) regimen has been shown to be effective as… 
Highly Cited
2002
Highly Cited
2002
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Treatment for patients with stage IV indolent lymphoma ranges from watchful waiting to intensive chemotherapy and stem cell… 
Highly Cited
2000
Highly Cited
2000
ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m−2 and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients
Cyclophosphamide 1.5 g m–2 followed by granulocyte colony-stimulating factor (G-CSF) is an effective peripheral blood stem cell… 
1999
1999
ESHAP as salvage therapy for refractory non-Hodgkin's lymphoma: Taiwan experience.
BACKGROUND The ESHAP regimen, a combination of the chemotherapeutic drugs etoposide, methylprednisolone (solumedrol), high-dose… 
Highly Cited
1998
Highly Cited
1998
Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia
Given the generally poor outcome of advanced B cell chronic lymphocytic leukemia, experimental approaches are warranted… 
1996
1996
Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
There are few reports of salvage chemotherapy for HIV-related non-Hodgkin's lymphoma (NHL). We report a relapsed HIV-related high… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)